ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 3 filers reported holding ABEONA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $19,000 | -34.5% | 92,409 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $29,000 | -6.5% | 92,409 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $31,000 | -69.9% | 92,409 | 0.0% | 0.00% | -81.8% |
Q3 2021 | $103,000 | -28.5% | 92,409 | 0.0% | 0.01% | -21.4% |
Q2 2021 | $144,000 | -17.2% | 92,409 | 0.0% | 0.01% | -22.2% |
Q1 2021 | $174,000 | +13.7% | 92,409 | -4.9% | 0.02% | +12.5% |
Q4 2020 | $153,000 | +54.5% | 97,173 | 0.0% | 0.02% | +45.5% |
Q3 2020 | $99,000 | -65.0% | 97,173 | 0.0% | 0.01% | -68.6% |
Q2 2020 | $283,000 | +18.4% | 97,173 | -14.6% | 0.04% | +34.6% |
Q1 2020 | $239,000 | -38.9% | 113,799 | -4.8% | 0.03% | -23.5% |
Q4 2019 | $391,000 | +44.8% | 119,493 | 0.0% | 0.03% | +61.9% |
Q3 2019 | $270,000 | -57.4% | 119,493 | -9.9% | 0.02% | -48.8% |
Q2 2019 | $634,000 | -41.9% | 132,615 | -10.5% | 0.04% | -37.9% |
Q1 2019 | $1,091,000 | -9.2% | 148,254 | -11.8% | 0.07% | +13.8% |
Q4 2018 | $1,201,000 | -66.2% | 168,151 | -39.5% | 0.06% | -50.4% |
Q3 2018 | $3,558,000 | -20.0% | 278,000 | 0.0% | 0.12% | -6.4% |
Q2 2018 | $4,448,000 | – | 278,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,359,767 | $3,481,000 | 1.41% |
DAFNA Capital Management LLC | 181,818 | $465,000 | 0.40% |
Perceptive Advisors | 1,762,881 | $4,512,000 | 0.40% |
SPHERA FUNDS MANAGEMENT LTD. | 468,050 | $1,198,000 | 0.26% |
Soros Fund Management | 1,462,122 | $3,743,000 | 0.08% |
SABBY MANAGEMENT, LLC | 334,108 | $855,000 | 0.04% |
KLCM Advisors, Inc. | 28,612 | $73,000 | 0.02% |
CAMBRIDGE TRUST CO | 65,414 | $167,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 35,400 | $91,000 | 0.01% |
IFP Advisors, Inc | 10,000 | $74,000 | 0.01% |